ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Extracorporeal Circulation

May 2, 2024
Aortic valve regurgitation (AR) often occurs after left ventricular assist device (LVAD) implantation. Transcatheter aortic valve implantation (TAVI) is a viable alternative to surgical aortic valve replacement (SAVR) in this cohort, most of whom have a high surgical risk profile. Procedure outcome and survival were analyzed.
April 18, 2024
This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy undergoing surgical revascularization.
January 11, 2024
In this article, the author describes three patients who had undergone previous mitral and aortic valve replacement, experiencing cardiogenic shock due to valve dysfunction. The initial evaluation demonstrated that the patients were deemed inoperable based on risk score calculations.
November 16, 2023
Patients younger than nineteen years old were included in a study developed to gain a better understanding of pediatric patients supported with ventricular assist devices (VADs). The authors found that illness at VAD implantation, diagnosis, and strategy of support affect survival and differ by device type.
November 16, 2023
ECMOSARS registry data was used to describe the characteristics and outcomes of COVID-19 patients undergoing either veno-arterial (VA) or veno-arterial venous (VAV) extracorporeal membrane oxygenation (ECMO).
November 6, 2023
An elegant and surprisingly easily read cohort study of mechanical destruction of platelets in ECMO circuits that parallels what we already know in pumps for full cardiopulmonary bypass. The authors propose a biomarker as a target for thrombotic modulation .
May 2, 2023
An interview with the winner of the 2022 Resident Video Competition.
May 2, 2023
This is the winning video in the 8th Annual Resident Video Competition.
January 20, 2023
Researchers conducted a literature analysis to weigh the benefits and risks of using Impella versus ECMO for use in cases of cardiogenic shock.
September 30, 2022
This editorial describes the evolving pathway of diagnosing a disease that is predicted to augment the indication for orthotopic cardiac transplantation. Cardiac involvement of sarcoidosis accounts for the majority of deaths in sarcoidosis patients, so it is important to better understand its symptoms.

Pages